EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,003 | +14.3% | 18,261 | 0.0% | 0.03% | +17.2% |
| Q2 2023 | $348,968 | -39.3% | 18,261 | -38.4% | 0.03% | -43.1% |
| Q1 2023 | $575,235 | +20.8% | 29,636 | -0.1% | 0.05% | +10.9% |
| Q4 2022 | $476,067 | +2.4% | 29,680 | +0.1% | 0.05% | -6.1% |
| Q3 2022 | $465,000 | -24.6% | 29,636 | 0.0% | 0.05% | -23.4% |
| Q2 2022 | $617,000 | -14.2% | 29,636 | -6.6% | 0.06% | -3.0% |
| Q1 2022 | $719,000 | +24.0% | 31,731 | 0.0% | 0.07% | +29.4% |
| Q4 2021 | $580,000 | -13.6% | 31,731 | 0.0% | 0.05% | -21.5% |
| Q3 2021 | $671,000 | +16.1% | 31,731 | 0.0% | 0.06% | +12.1% |
| Q2 2021 | $578,000 | -9.3% | 31,731 | 0.0% | 0.06% | -19.4% |
| Q4 2020 | $637,000 | -16.7% | 31,731 | -1.6% | 0.07% | -48.6% |
| Q2 2020 | $765,000 | – | 32,231 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |